Abstract:Background: Mathematical models can be useful tools in exploring disease trends and health consequences of interventions in a population over time. Most cancers, in particular cervical cancer, have long incubation periods. The time from acquisition of HPV infection to development of invasive cancer can be up to two decades or more. Mathematical models can be used to translate short-term findings from prevention and mitigations trials into predictions of long-term health outcomes. The main objective of this paper is to develop a mathematical model of HPV for African American women (AAW) in the United States and give quantitative insight into current U.S. prevention and mitigations against cervical cancer. Methods: A compartmental mathematical model of the cycle of HPV that includes the choices individuals make once they become infected; treatment versus no treatment, was developed. Using this mathematical model we evaluated the impact of human papillomavirus (HPV) on a given population and determined what could decrease the rate at which AAW become infected. All state equations in the model were approximated using the Runge-Kutta 4(th) order numerical approximation method using MatLab software. Results: In this paper we found that the basic reproductive number R(OU) is directly proportional to the rate of infectivity of HPV and the contact rate in which a human infects another human with HPV. The R(OU) was indirectly proportional to the recovery rate plus the mortality by natural causes and the disease. The second R(OT) is also directly proportional to the rate of infectivity of HPV and contact rate in which humans infect another human with HPV and indirectly proportional to the recovery rate plus the mortality from HPV related cause and natural causes. Based on the data of AAW for the parameters; we found that R(OU) and R(OT)were 0.519798 and 0.070249 respectively. As both of these basic reproductive numbers are less than one, infection cannot therefore get started in a fully susceptible population, however, if mitigation is to be implemented effectively it should focus on the HPV untreated population as R(OT)is greater than 0.5. Conclusion: Mathematical models, from individual and population perspectives, will help decision makers to evaluate different prevention and mitigation measures of HPV and deploy synergistically to improve cancer outcomes. Integrating the best-available epidemiologic data, computer-based mathematical models used in a decision-analytic framework can identify those factors most likely to influence outcomes and can help in formulating decisions that need to be made amidst considerable lack of data and uncertainty. Specifically, the model provides a tool that can accommodate new information, and can be modified as needed, to iteratively assess the expected benefits, costs, and cost-effectiveness of different policies in the United States. This model can help show the direct relationship between HPV and cervical cancer. If any of the rates change it will greatly impact the graphs. These graphs can be used to discover new methods of treatment that will decrease the rate of infectivity of HPV and Cervical cancer with time.

From primary HPV infection to carcinoma in situ: A mathematical approach to cervical intraepithelial neoplasia

From primary HPV infection to carcinoma in situ: a mathematical approach of cervical intraepithelial neoplasia

Clinical Analysis of 72 Cases of Cervical Intraepithelial Neoplsia

Clinical and Pathological Analysis of 120 Cases Cervical Intraepithelial Neoplasia

In-host density-dependent model of high-risk HPV virions, basal cells, lymphocytes t-cells incorporating functional responses

Predicting cervical intraepithelial neoplasia and determining the follow-up period in high-risk human papillomavirus patients

Exploring the dynamics and interplay of human papillomavirus and cervical tumorigenesis by integrating biological data into a mathematical model

Extended Human Papilloma Virus Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2 or Worse in a Cohort Study

[Research on the Oncogenesis of Cervical Epithelial Cells Co-Induced by Human Papillomavirus and Human Cytomegalovirus].

Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Emerging trends and hotspots in cervical intraepithelial neoplasia research from 2013 to 2023: A bibliometric analysis

The immediate risk of cancer and its precursor lesions in women with abnormal cervical glandular cytology

Factors in the Formation of Neoplastic Processes in the Cervix

Correlation analysis of human papillomavirus E6/E7 mRNA detection with diagnosis, prognosis and recurrence risk in patients with cervical epithelioma

108 Cases of Cervical Intraepithelial Neoplasia:A Clinicopathological Analysis

Does the Core Position of Cervical Microbial Community Analysis in Predicting CIN Malignant Transformation?

From Diagnosis to Treatment: Exploring the Latest Management Trends in Cervical Intraepithelial Neoplasia

A Mathematical Model of Human Papillomavirus (HPV) in the United States and its Impact on Cervical Cancer

Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia

The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions

Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions